EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

LUNGevity Takes Step Forward in Clinical Trial Eligibility Reform for Lung Cancer Patients

LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, is pleased to announce the publication of recommendations that will create more...
20 June 2018 Europe clinical | eligibility
Continue Reading →
Europe

CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD

Patient enrollment proceeding under amended protocol CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company developing new antibody therapies for combating human immuno...
20 June 2018 Europe clinical | CytoDyn
Continue Reading →
Europe

Xynomic Pharma Plans 4 Clinical Trials of Abexinostat for Lymphoma

 Xynomic Pharma announced it has completed a new Series B financing round and now will initiate eight clinical trials, four of which are for different types of lympho...
13 June 2018 Europe Abexinostat | clinical
Continue Reading →
Europe

Epsom and St Helier staff celebrate International Clinical Trials Day

Staff and researchers celebrated the healthcare advances made possible by clinical research at Epsom and St Helier Hospitals for this year’s International Clinical Tr...
13 June 2018 Europe | North America celebrate | clinical
Continue Reading →
Europe

Doctors Call Off Clinical Trial After Experimental Cancer Treatment Has Tragic Results

 A recent clinical trial attempting to rid three patients of an uncommon type of blood cancer has gone tragically wrong. Rather than fighting the cancer that was rava...
13 June 2018 Europe cancer | clinical
Continue Reading →
Europe

PCI’s Brian Keesee Set to Bolster Global Clinical Operations and Supply

Leading pharmaceutical outsourcing provider PCI Pharma Services is delighted to announce the promotion of Brian Keesee to the new position of Vice President and Gener...
7 June 2018 Europe bolster | Brian
Continue Reading →
Europe

7th Annual Publication and Clinical Trial Transparency

Date: June 20-21, 2018 Location: Amsterdam, The Netherlands In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge between the key stak...
6 June 2018 Europe 7th | annual
Continue Reading →
Europe

Speeding Drug Development with Clinical Trials in a Dish

The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory hurdles. Any technology or methodology that can exped...
6 June 2018 Europe clinical | development
Continue Reading →
Europe

NCI-MATCH precision medicine clinical trial releases new findings

The National Cancer Institute's Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has achieved a milestone wi...
6 June 2018 Europe ASCO | clinical
Continue Reading →
Europe

Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer

SOTIO, a biotechnology company owned by the PPF Group, presented results from its Phase II clinical trials evaluating DCVAC, an active cellular immunotherapy product,...
6 June 2018 Europe clinical | DCVAC
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte